1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
60215D564C1DA3EBA65257DFF00296332
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/developing-high-impact-communication-forms-to-brief-senior-leaders-optimizing-competitive-assessment-data-disclosure-summaries
18
19
2054.161.31.247
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Products & Services Business Communications Internal Communication Excellence

Developing High-Impact Communication Forms to Brief Senior Leaders: Optimizing Competitive Assessment & Data Disclosure Summaries

ID: PSM-318


Features:

13 Info Graphics

15 Data Graphics

300+ Metrics


Pages: 33


Published: 2015


Delivery Format: Shipped


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

Buy this research as part of a

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Competitive and clinical landscape assessments are crucial to the success of new products in the pharmaceutical industry. If done right, executive briefs provide senior leadership with a concise understanding of the market and enable them to make key decisions around challenges and opportunities that exist based on competitor companies and products.

Best Practices, LLC undertook this study to supply Competitive and Business Intelligence leaders with insights into creating effective Market Landscape Summaries, Clinical Development Profile Maps, and other critical executive briefs. This study will aid Market Intelligence & Analytics leaders in crafting high-impact landscape assessments that meet the needs of senior leadership.


Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Chemical; Manufacturing; Consumer Products; Consulting; Medical Device; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
Abbott; Zydus; King Pharmaceuticals; Genentech; Mallinckrodt; Bayer Healthcare; Merck; Lac Mac; Merck Serono; Alembic; Novo Nordisk; Lilly; Pfizer; Boehringer Ingelheim; Pharma Consulting; actavis; ProStrakan; Cadila Pharmaceuticals; Quintiles; Amgen; Ranbaxy; Daiichi Sankyo; Roche; Rxperts; Sanofi; Shire; Vivus


Study Snapshot

This study engaged 30 executives from 27 leading pharmaceutical, biotech, and life sciences companies. Twelve research participants represented large pharma organizations, while the remaining benchmark class emerged from mid-sized and smaller companies.

Deep-dive interviews were conducted with senior bio-pharma leaders with experience on Boards of Directors and in the roles of Chief Executive, Chief Marketing Officer, Chief Medical Officer, and Head of Competitive and Business Intelligence.

Key Findings

Use 5 Pages or Fewer for Competitive Landscape Assessments: Very concise executive briefs work best for presenting market landscape summaries to different leadership groups. More than half of benchmark partners use 5 pages or fewer for presentations to all groups. Competitive assessments to Investor Relations groups are often the most concise presentation type, while those to Executive Committees may run longer.


Table of Contents

I. Executive Summary pgs. 3-8
Research Overview pg. 3
Participating Companies pg. 4
Key Recommendations pg. 5
Key Findings & Insights pgs. 6-9
II. Crafting a High-Impact Competitive Landscape pgs. 10-16
Assessment Template
III. Crafting a High-Impact Clinical Development pgs. 17-22
Assessment Template
IV. Reporting Structures & Processes for pgs. 23-29
V. Maximizing Competitive Assessment Impact
VI. Benchmark Profile pgs. 30-32

List of Charts & Exhibits

Highly Important Market & Clinical Factors to Include in Assessments
Length of Competitive Landscape Assessment Template
Length of Clinical Development / Data Disclosure Summary Template
Most Important Basic Components in 1-Page Competitive Assessment Template
Key Competitor Insights in 1-Page Competitive Assessment Template
Most Critical Components of a Successful Competitive Assessment Template
Highly Important Product Features to Include in Clinical Assessments
Key New Product Timing Components in 1-Page Assessment Template
Key Trial Design Strategy Insights in 1-Page Clinical Landscape Template
Key Competitive Insights in 1-Page Clinical Landscape Template
Standards of Excellence for Ease of Interpreting Template
Competitive Assessments for New vs. In-line Products
Management of Competitive Assessments
Sharing Competitive Assessments within Organization
Competitive Assessment Report Delivery Model
Best Channels to Communicate the Landscape Template